Provider review
Medi-Weightloss review
Publishes a first-month price for both molecules and no standing rate for either.
A reader can find out what the opening charge is on either molecule, and cannot find out anywhere what the second month costs. In-person clinics rather than a purely remote service.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Medi-Weightloss
$99 first month sema · $199 first month tirz, no standing rate
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo across 242 of 373
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Both prices here are labeled first month, and that label is doing all the work. A reader can establish what the opening charge is on either molecule and cannot establish, anywhere on the site, what the month after it costs — which on a treatment measured in months rather than weeks leaves the entire budgeting question unanswered. Introductory pricing is ordinary in this category; publishing it with no standing rate beside it is what makes this one impossible to plan around. The visit charge adds a second variable, quoted as a range that depends on insurance coverage and deductible, so even the first month does not resolve to a single number. What genuinely distinguishes the business is that it is a clinic network rather than a purely remote seller — there is a find-a-clinic flow and the appointments happen in person, which some readers will much prefer to a video call and a shipment. It accepts FSA and HSA funds, and it dispenses name-brand medication where a reader insurance covers it, which is a real alternative rather than a compounded-only shelf. None of that changes the central problem: you cannot cost a year here from anything published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You would rather be seen in person than manage everything through a screen.
- You have insurance that may cover a name-brand medication.
- You want to pay with FSA or HSA funds.
Look elsewhere if
- You need to know what month two costs. No standing rate is published anywhere.
- You want a single first-month figure. The visit charge is an insurance-dependent range.
- You are pricing a dose. None is published behind either figure.
What it actually costs
Price as published
Compounded semaglutide "$99 first month" and compounded tirzepatide "$199 first month" — both figures are explicitly labeled as introductory, and nothing published anywhere says what either costs in month two · a visit cost of "between $0 and $50 per visit when using insurance" sits on top, depending on coverage and deductible · it also offers name-brand medication where insurance covers it, and accepts FSA and HSA payment · ★ this is a clinic network rather than a telehealth-only seller, with a "find a clinic near you" flow, so the visits are in person · a first-month figure with no standing rate behind it is the least plannable shape a published price can take: it tells a reader what they pay once and nothing about the year they are being asked to commit to
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- No low-dose price published
A low-dose lane may exist, but nothing public says what it costs — so the one question this page exists to answer cannot be answered before you sign up.
52 of the 373 programs we track price a small dose this way. Both published figures are FIRST-MONTH prices and no standing rate appears anywhere, so nothing readable before intake tells a reader what any month after the first costs. A visit charge on top is quoted as an insurance-dependent range. Nothing here can be costed over a year.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Billed separately
- Dietitian
- Included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- In-person clinic visits rather than a purely remote service, with a find-a-clinic flow.
- Offers name-brand medication where insurance covers it, not only compounded preparations.
- Accepts FSA and HSA payment.
Pharmacy, labs and oversight
Medi-Weightloss dispenses through a Not named facility. No bloodwork is required before you start. A clinician review is billed separately.
Transparency check
2 of 4 published openly
What Medi-Weightloss publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Both prices here are labeled first month, and that label is doing all the work. A reader can find out what the opening charge is on either molecule and cannot find out, anywhere on the site, what the second month costs — which on a treatment measured in months rather than weeks is the whole budgeting question left unanswered. Introductory pricing is common in this category; publishing it without a standing rate beside it is what makes this one hard to plan around. The visit cost adds a second variable, quoted as a range that depends on insurance coverage and deductible, so even the first month is not a single number. What distinguishes the business is that it is a clinic network rather than a purely remote seller — there is a find-a-clinic flow and the visits happen in person, which some readers will prefer to a video call and a shipment, and it accepts FSA and HSA funds. It also dispenses name-brand medication where a reader's insurance covers it, which is a genuine option rather than a compounded-only shelf. None of that changes the central problem: you cannot cost a year here from what is published.
The honest cons
Both published figures are first-month prices, and no standing rate appears anywhere.
- The visit cost is a range that depends on your insurance, so even the first month is not one number.
- No dose is published behind either figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Medi-Weightloss is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#194 of 373
Ordered with the companies that pay us first, and Medi-Weightloss is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Care Bare Rx
From $199/mo*
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Care Bare Rx review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.